International Journal of Clinical & Medical Microbiology Volume 1 (2016), Article ID 1:IJCMM-101, 2 pages
A Putative Fifth Serotype of Dengue - Potential Implications for Diagnosis, Therapy and Vaccine Design

Andrew W. Taylor-Robinson

School of Medical & Applied Sciences, Central Queensland University, Rockhampton, QLD 4702, Australia
Prof Andrew W. Taylor-Robinson, School of Medical & Applied Sciences, Central Queensland University, Bruce Highway, Rockhampton, QLD 4702, Australia. Tel: +61 7 4923 2008; E-mail:
08 December 2015; 28 February 2016; 03 March 2016
Taylor-Robinson AW (2016) A Putative Fifth Serotype of Dengue - Potential Implications for Diagnosis, Therapy and Vaccine Design. Int J Clin Med Microbiol 1: 101. doi:


  1. WHO (2009) Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. Geneva: World Health Organization. 160 pp [Google Scholar]
  2. slam R, Salahuddin M, Ayubi MS, Hossain T, Majumder A, et al. (2015) Dengue epidemiology and pathogenesis: images of the future viewed through a mirror of the past. Virol Sin 30: 326-343 [CrossRef] [Google Scholar] [PubMed]
  3. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, et al. (2013) The global distribution and burden of dengue. Nature 496: 504-507 [CrossRef] [Google Scholar] [PubMed]
  4. Gubler DJ (1998) Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 11: 480-496 [CrossRef] [Google Scholar] [PubMed]
  5. Halstead SB (2007) Dengue. Lancet 370: 1644-1652 [CrossRef] [Google Scholar] [PubMed]
  6. Burke DS, Monath TP (2001) Flavivirus. In: Knipe DM, Howley PM (Eds) Fields Virology (vol 1, 4th ed), Philadelphia: Lippincott Williams & Wilkins 1043-1126
  7. Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, et al. (2010) Dengue: a continuing global threat. Nat Rev Microbiol 8: S7-S16 [CrossRef] [Google Scholar] [PubMed]
  8. Endy TP, Chunsuttiwat S, Nisalak A, Libraty DH, Green S, et al. (2002) Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am J Epidemiol 156: 40-51 [CrossRef] [Google Scholar] [PubMed]
  9. Leitmeyer KC, Vaughn DW, Watts DM, Salas R, Villalobos I, et al. (1999) Dengue virus structural differences that correlate with pathogenesis. J Virol 73: 4738-4747 [Google Scholar] [PubMed]
  10. Sanyal S, Taylor-Robinson AW (2013) Host-virus interactions in dengue infection indicate targets for detection and therapeutic interventions. Immun Dis 1: 71-74 [CrossRef]
  11. Ansari S, Taylor-Robinson AW (2014) Strategic approaches to multivalent vaccine development against dengue virus infection. Annal Vaccines Immunization 1: 1005-1012
  12. Halstead SB, Heinz FX, Barrett AD, Roehrig JT (2005) Dengue virus: molecular basis of cell entry and pathogenesis, 25-27 June 2003, Vienna, Austria. Vaccine 23: 849-856 [CrossRef] [Google Scholar] [PubMed]
  13. Normile D (2013) Tropical medicine. Surprising new dengue virus throws a spanner in disease control efforts. Science 342: 415 [CrossRef] [Google Scholar] [PubMed]
  14. da Silva Voorham JM (2014) [A possible fifth dengue virus serotype]. Ned Tijdschr Geneeskd 158: A7946 [Google Scholar] [PubMed]
  15. Mustafa MS, Rasotgi V, Jain S, Gupta V (2015) Discovery of fifth serotype of dengue virus (DENV-5): A new public health dilemma in dengue control. Med J Armed Forces India 71: 67-70 [CrossRef] [Google Scholar] [PubMed]
  16. Wiwanitkit S, Wiwanitkit V (2015) Acute viral hemorrhage disease: a summary on new viruses. J Acute Dis 4: 277-279 [CrossRef] [Google Scholar]
  17. Vasilakis N, Durbin AP, da Rosa AP, Munoz-Jordan JL, Tesh RB, et al. (2008) Antigenic relationships between sylvatic and endemic dengue viruses. Am J Trop Med Hyg 79: 128-132 [CrossRef] [Google Scholar] [PubMed]
  18. Inoue S, Morita K, Matias RR, Tuplano JV, Resuello RR, et al. (2003) Distribution of three arbovirus antibodies among monkeys (Macaca fascicularis) in the Philippines. J Med Primatol 32: 89-94 [CrossRef] [Google Scholar] [PubMed]
  19. Hirschmann JV (1997) Fever of unknown origin in adults. Clin Infect Dis 24: 291-300 [CrossRef] [Google Scholar] [PubMed]
  20. Efstathiou SP Pefanis AV, Tsiakou AG, Skeva II, Tsioulos DI, et al. (2010) Fever of unknown origin: discrimination between infectious and noninfectious causes. Eur J Intern Med 21: 137-143 [CrossRef] [Google Scholar] [PubMed]
  21. Susilawati TN, McBride WJ (2014) Undiagnosed undifferentiated fever in Far North Queensland, Australia: a retrospective study. Int J Infect Dis 27: 59-64 [CrossRef] [Google Scholar] [PubMed]
  22. Forshey BM, Guevara C, Laguna-Torres VA, Cespedes M, Vargas J, et al. (2010) Arboviral etiologies of acute febrile illnesses in Western South America, 2000-2007. PLoS Negl Trop Dis 4: e787 [CrossRef] [Google Scholar] [PubMed]
  23. Jentes ES, Robinson J, Johnson BW, Conde I, Sakouvougui Y, et al. (2010) Acute arboviral infections in Guinea, West Africa, 2006. Am J Trop Med Hyg 83: 388-394 [CrossRef] [Google Scholar] [PubMed]
  24. Subedi D, Taylor-Robinson AW (2014) Laboratory diagnosis of dengue infection: current techniques and future strategies. Open J Clin Diagn 4: 63-70 [CrossRef] [Google Scholar]
  25. Liang G, Gao X, Gould EA (2015) Factors responsible for the emergence of arboviruses; strategies, challenges and limitations for their control. Emerg Microbes Infect 4: e18 [CrossRef] [Google Scholar] [PubMed]
  26. Subedi D, Taylor-Robinson AW (2015) Development of a dengue vaccine in humans: so near, yet so far. SOJ Vaccine Res 1: 7-13 [Google Scholar]
  27. Vannice KS, Roehrig JT, Hombach J (2015) Next generation dengue vaccines: A review of the preclinical development pipeline. Vaccine 33: 7091-7099 [CrossRef] [Google Scholar] [PubMed]
  28. Coller BA, Clements DE (2011) Dengue vaccines: progress and challenges. Curr Opin Immunol 23: 391-398 [CrossRef] [Google Scholar] [PubMed]
  29. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, et al. (2000) Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181: 2-9 [CrossRef] [Google Scholar] [PubMed]
  30. Whitehead SS, Falgout B, Hanley KA, Blaney JE Jr, Markoff L, et al. (2003) A live, attenuated dengue virus type 1 vaccine candidate with a 30-nucleotide deletion in the 3' untranslated region is highly attenuated and immunogenic in monkeys. J Virol 77: 1653-1657 [CrossRef] [Google Scholar] [PubMed]